NM_002473.6:c.3195_3215dupCGAGCTCCAGGCCCAGATCGC
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP3
The NM_002473.6(MYH9):c.3195_3215dupCGAGCTCCAGGCCCAGATCGC(p.Ala1072_Glu1073insGluLeuGlnAlaGlnIleAla) variant causes a disruptive inframe insertion change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_002473.6 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH9 | NM_002473.6 | c.3195_3215dupCGAGCTCCAGGCCCAGATCGC | p.Ala1072_Glu1073insGluLeuGlnAlaGlnIleAla | disruptive_inframe_insertion | Exon 25 of 41 | ENST00000216181.11 | NP_002464.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH9 | ENST00000216181.11 | c.3195_3215dupCGAGCTCCAGGCCCAGATCGC | p.Ala1072_Glu1073insGluLeuGlnAlaGlnIleAla | disruptive_inframe_insertion | Exon 25 of 41 | 1 | NM_002473.6 | ENSP00000216181.6 | ||
MYH9 | ENST00000685801.1 | c.3258_3278dupCGAGCTCCAGGCCCAGATCGC | p.Ala1093_Glu1094insGluLeuGlnAlaGlnIleAla | disruptive_inframe_insertion | Exon 26 of 42 | ENSP00000510688.1 | ||||
MYH9 | ENST00000459960.1 | n.404_424dupCGAGCTCCAGGCCCAGATCGC | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
MYH9 | ENST00000691109.1 | n.3490_3510dupCGAGCTCCAGGCCCAGATCGC | non_coding_transcript_exon_variant | Exon 19 of 35 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The MYH9 c.3195_3215dup; p.Gln1068_Leu1074dup variant (rs876661302; ClinVar ID: 14085), also reported as E1066_A1072dup, is reported in an individual with moderate thrombocytopenia, large platelets and moderate/severe bleeding, but with no current extra-hematological symptoms (Bury 2020). This variant has also been reported to segregate with MYH9-related disease in three affected individuals of a family (De Rocco 2009). This variant duplicates seven amino acids leaving the rest of the protein in-frame. Based on available information, this variant is considered to be pathogenic. References: Bury L et al. Next-generation sequencing for the diagnosis of MYH9-RD: Predicting pathogenic variants. Hum Mutat. 2020 Jan;41(1):277-290. PMID: 31562665. De Rocco D et al. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within -
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at